{"id":20468,"date":"2022-02-16T02:10:00","date_gmt":"2022-02-16T02:10:00","guid":{"rendered":"https:\/\/eodishasamachar.com\/en\/2022\/02\/16\/teledyne-e2v-and-leo-cancer-care-partner-to-achieve-an-innovative-minimal-platform-footprint\/"},"modified":"2022-02-16T02:10:00","modified_gmt":"2022-02-16T02:10:00","slug":"teledyne-e2v-and-leo-cancer-care-partner-to-achieve-an-innovative-minimal-platform-footprint","status":"publish","type":"post","link":"https:\/\/eodishasamachar.com\/en\/2022\/02\/16\/teledyne-e2v-and-leo-cancer-care-partner-to-achieve-an-innovative-minimal-platform-footprint\/","title":{"rendered":"Teledyne e2v and Leo Cancer Care Partner to Achieve an Innovative Minimal Platform Footprint"},"content":{"rendered":"<p> \n<\/p>\n<div lang=\"en\">\n<p>SURREY, UNITED KINGDOM &#8211;\u00a0<a href=\"https:\/\/www.media-outreach.com\/\" rel=\"sponsored\">Media<br \/>\nOutReach<\/a>\u00a0&#8211; 16 February 2022 &#8211; Leo<br \/>\nCancer Care is driving a paradigm shift in the radiation therapy market,<br \/>\ndeveloping solutions where the patient is in the upright orientation, removing<br \/>\nthe need for large and expensive gantries and instead utilising a fixed<br \/>\nradiation beam and rotating the patient.<\/p>\n<p align=\"center\"><img width=\"500\" data-src=\"https:\/\/images.media-outreach.com\/Thumb\/500x0\/220083\/LCC-Te2v-photo.jpg#image-220083\" class=\"lazyload\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\"\/><\/p>\n<p><noscript><img src=\"https:\/\/images.media-outreach.com\/Thumb\/500x0\/220083\/LCC-Te2v-photo.jpg#image-220083\" width=\"500\"\/><\/noscript><\/p>\n<p>Leo Cancer Care is focused<br \/>\non delivering a family of products designed for the economics of the future, meeting<br \/>\ncustomers&#8217; clinical and financial needs. Ruby\u2122 is a smaller, more streamlined<br \/>\nPhoton Therapy Solution which will reduce setup times and therefore save<br \/>\ninstitutions money by increasing patient throughput. Ruby\u2122 can come<br \/>\nself-shielded meaning no need for expensive bunkers. Leo Cancer Care has a<br \/>\nvision to make Ruby\u2122 mobile, in the not-too-distant future, taking radiation<br \/>\ntherapy to places it has never been before.<\/p>\n<p>\u00a0<\/p>\n<p>In addition to the<br \/>\noperational and financial benefits of this technology, the Leo Cancer Care<br \/>\nsolutions have been developed on the back of research from across the globe,<br \/>\ndemonstrating the clinical benefits of upright patient positioning through<br \/>\nreduced organ motion. Combined with a real focus on patient experience, helping<br \/>\npatients to feel more comfortable and in control of their radiation therapy<br \/>\ntreatment journey.<\/p>\n<p>Teledyne<br \/>\ne2v has been working with Leo Cancer Care to enable them to achieve their<br \/>\ninnovative minimal platform footprint.\u00a0<br \/>\nThis has been done by designing a compact RF sub-system, which will<br \/>\ninclude a new solid-state modulator to drive one of its range of magnetrons and<br \/>\nthe integration of other RF accessories.\u00a0\n<\/p>\n<p>\u00a0<\/p>\n<p>Continuing<br \/>\nto build on its position as the world leader in generating RF power for<br \/>\nradiation therapy, Teledyne e2v will be providing its very latest technology to<br \/>\nsupport this exciting development, based on over 70 years of experience.\u00a0 <\/p>\n<p><i>&#8220;With Ruby<\/i><i>\u2122 being smaller and more compact than conventional<br \/>\ntechnology, have really driven to reduce the size of all of our components. Teledyne E2V is supporting us to do this and we are<br \/>\nmoving at pace to bring Ruby<\/i>\u2122 to the market. <i>Together we<br \/>\nhave the innovative technology, trusted products and combined experience in the<br \/>\nRadiation Oncology field to change how photon radiation therapy is delivered<br \/>\nand how a patient experiences it&#8221;.\u00a0 <\/i>Stephen<i> <\/i>Towe, CEO<i> <\/i>Leo Cancer Care.<\/p>\n<p>Leo Cancer Care: <\/p>\n<p><a href=\"https:\/\/www.leocancercare.com\/\" rel=\"sponsored\"><i>https:\/\/www.leocancercare.com\/<\/i><\/a><\/p>\n<p>#Teledynee2v #LeoCancerCare<\/p>\n<\/p><\/div>\n\n<br \/><a href=\"https:\/\/www.media-outreach.com\/news\/united-kingdom\/2022\/02\/16\/119976\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SURREY, UNITED KINGDOM &#8211;\u00a0Media OutReach\u00a0&#8211; 16 February 2022 &#8211; Leo Cancer Care is driving a paradigm shift in the radiation therapy market, developing solutions where the patient is in the upright orientation, removing the need for large and expensive gantries and instead utilising a fixed radiation beam and rotating the patient. Leo Cancer Care is &hellip;<\/p>\n","protected":false},"author":1,"featured_media":20469,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[60],"tags":[],"_links":{"self":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts\/20468"}],"collection":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/comments?post=20468"}],"version-history":[{"count":0,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts\/20468\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/media\/20469"}],"wp:attachment":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/media?parent=20468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/categories?post=20468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/tags?post=20468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}